Research in visceral leishmaniasis in the last decade has been focused on how better to
use the existing medicines as monotherapy or in combination. Systematic research by …

The leishmaniases are protozoan infections that are among the neglected tropical diseases
(NTDs). Over one billion people are at risk of these diseases in virtually all continents. These …

Background Neglected Tropical Diseases (NTDs) are important causes of morbidity,
disability, and mortality among poor and vulnerable populations in several countries …

Methods We extracted information on cause of death, age, sex, ethnicity and place of
residence from the nationwide mortality information system at the Brazilian Ministry of …

Background The study presents estimates for the burden of visceral leishmaniasis (VL) and
cutaneous and mucocutaneous leishmaniasis (CML) in Brazil and its 27 federated units …

Human leishmaniosis caused by Leishmania infantum is an important health problem
worldwide. One of the main aspects arousing interest is the epidemiological scenario …

INTRODUCTION Visceral leishmaniasis (VL) is a neglected disease, with territorial
expansion and regional differences in Brazil that require explanation. This study aimed to …

Worldwide, an estimated 12 million people are infected with Leishmania spp. and an
additional 350 million are at risk of infection. Leishmania are intracellular parasites that …

Background Miltefosine has been used successfully to treat visceral leishmaniasis (VL) in
India, but it was unsuccessful for VL in a clinical trial in Brazil. Methods To identify molecular …

Climate change is having a substantial impact on our environment and ecosystems and has
altered the way humans live, access, and utilize resources with increased risk of zoonotic …